Literature DB >> 29582931

Thromboembolic Risks of Non-Factor Replacement Therapies in Hemophilia.

A Tiede.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29582931     DOI: 10.5482/20170004

Source DB:  PubMed          Journal:  Hamostaseologie        ISSN: 0720-9355            Impact factor:   1.778


× No keyword cloud information.
  6 in total

Review 1.  Non-factor replacement therapy for haemophilia: a current update.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Blood Transfus       Date:  2018-02-14       Impact factor: 3.443

2.  Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis.

Authors:  Koji Yada; Keiji Nogami; Kenichi Ogiwara; Yasuaki Shida; Shoko Furukawa; Hiroaki Yaoi; Masahiro Takeyama; Ryu Kasai; Midori Shima
Journal:  Int J Hematol       Date:  2019-06-28       Impact factor: 2.490

3.  Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database.

Authors:  Steven W Pipe; Rebecca Kruse-Jarres; Johnny N Mahlangu; Glenn F Pierce; Flora Peyvandi; Peter Kuebler; Christian De Ford; Fabián Sanabria; Richard H Ko; Tiffany Chang; Charles R M Hay
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

4.  Application of a hemophilia mortality framework to the Emicizumab Global Safety Database.

Authors:  Flora Peyvandi; Johnny N Mahlangu; Steven W Pipe; Charles R M Hay; Glenn F Pierce; Peter Kuebler; Rebecca Kruse-Jarres; Midori Shima
Journal:  J Thromb Haemost       Date:  2021-01       Impact factor: 5.824

5.  [Recent advances in therapies for haemophilia].

Authors:  B Y Sun; R C Yang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14

6.  Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.

Authors:  Hans H Brackmann; Wolfgang Schramm; Johannes Oldenburg; Viridiana Cano; Peter L Turecek; Claude Négrier
Journal:  Hamostaseologie       Date:  2020-07-27       Impact factor: 2.145

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.